These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 3322638)
1. Development of antiviral agents for the treatment of human immunodeficiency virus infection. Tartaglione TA; Collier AC Clin Pharm; 1987 Dec; 6(12):927-40. PubMed ID: 3322638 [TBL] [Abstract][Full Text] [Related]
2. [The present and future of AIDS chemotherapy]. Stanková M Cas Lek Cesk; 1993 Jun; 132(11):321-8. PubMed ID: 8339310 [TBL] [Abstract][Full Text] [Related]
3. Molecular biological assessment methods and understanding the course of the HIV infection. Katzenstein TL APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050 [TBL] [Abstract][Full Text] [Related]
4. Antiretroviral chemotherapy of human immunodeficiency virus infections other than with azidothymidine. Sachs MK Arch Intern Med; 1992 Mar; 152(3):485-501. PubMed ID: 1546911 [TBL] [Abstract][Full Text] [Related]
5. Antiviral drugs other than zidovudine and immunomodulating therapies in human immunodeficiency virus infection. An overview. Clumeck N; Hermans P Am J Med; 1988 Aug; 85(2A):165-72. PubMed ID: 2457313 [TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy and immunoprophylaxis of HIV infection]. Vogt M; Schooley RT; Hirsch MS Schweiz Rundsch Med Prax; 1986 Nov; 75(48):1471-5. PubMed ID: 2432642 [No Abstract] [Full Text] [Related]
8. Therapy other than reverse transcriptase inhibitors for HIV infection. Kaplan JC; Hirsch MS Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020 [TBL] [Abstract][Full Text] [Related]
9. Progress in the development of antiviral therapy for HTLV-III-associated diseases. Yarchoan R; Broder S Important Adv Oncol; 1987; ():293-311. PubMed ID: 2841232 [No Abstract] [Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
12. Antiviral drug development for the treatment of human immunodeficiency virus infections. An overview. Hirsch MS Am J Med; 1988 Aug; 85(2A):182-5. PubMed ID: 3044083 [TBL] [Abstract][Full Text] [Related]
13. Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. Sandström EG; Kaplan JC Drugs; 1987 Sep; 34(3):372-90. PubMed ID: 2824170 [TBL] [Abstract][Full Text] [Related]
14. Zidovudine for the treatment of HIV infection. Pepe R; Molavi A Am Fam Physician; 1990 Aug; 42(2):437-43. PubMed ID: 2200250 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral drug treatment for HIV/AIDS. Goldschmidt RH; Moy A Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838 [TBL] [Abstract][Full Text] [Related]
16. Reductions in viral load and increases in T lymphocyte numbers in treatment-naive patients with advanced HIV-1 infection treated with ritonavir, zidovudine and zalcitabine triple therapy. Mathez D; Bagnarelli P; Gorin I; Katlama C; Pialoux G; Saimot G; Tubiana P; De Truchis P; Chauvin JP; Mills R; Rode R; Clementi M; Leibowitch J Antivir Ther; 1997 Jul; 2(3):175-83. PubMed ID: 11322272 [TBL] [Abstract][Full Text] [Related]
17. The role of didanosine in the management of HIV-1 infection. Gazzard BG; Moyle GJ Antivir Ther; 1997 Jul; 2(3):135-47. PubMed ID: 11322269 [TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome. Montefiori DC; Robinson WE; Mitchell WM AIDS Res Hum Retroviruses; 1989 Apr; 5(2):193-203. PubMed ID: 2469450 [TBL] [Abstract][Full Text] [Related]
19. Reverse transcriptase activity (RTA) in lymphocyte cultures of HIV-infected patients receiving short treatments of HPA 23. A biological evaluation. Vittecoq D; Woerle R; Barre-Sinoussi F; Chermann JC Biomed Pharmacother; 1988; 42(1):35-9. PubMed ID: 2457397 [TBL] [Abstract][Full Text] [Related]